Prof Sharon Lewin
Director, Peter Doherty Institute
Department of Infectious Diseases
620 Scholarly works
168 Projects
HIGHLIGHTS
2026
Journal article
Recommendations from the 2nd Consensus Workshop on Analytical Treatment Interruption in HIV Research Trials
DOI: 10.1016/S2352-3018(25)00373-X2026
Journal article
Methaneseleninic acid, a circadian-modulating agent, reactivates latent HIV-1 infection without cellular activation or proliferation
DOI: 10.1128/jvi.01983-252026
Journal article
Integrating HIV services in an era of global change
DOI: 10.1002/jia2.700872026
Journal article
Innate antiviral and immune functions associated with the HIV reservoir decay after anti-PD-1 therapy
DOI: 10.1038/s41591-025-04139-y2024
Research contracts (non-grants)
UoM-Bonn Collaborative Research Agreement for the Cumming Global Centre for Pandemic Therapeutics
2024
Research contracts (non-grants)
Doherty Institute Strategic Partnership for Prevention, Surveillance and Response to Infectious Diseases Across the Indo-Pacific Region
2019
Research Grant
Addressing the Major Challenges in Hiv Vaccine and Cure Research
RECENT SCHOLARLY WORKS
2026
Journal article
Kinetics and Predictors of Hepatitis B Surface Antigen Loss After Commencing Hepatitis B Virus (HBV)–Active Antiretroviral Therapy in the Setting of HIV and Chronic HBV Coinfection
DOI: 10.1093/cid/ciaf2812026
Journal article
The effect of combining HIV latency reversal with inhibition of phosphoinositide-3 kinases or B-cell lymphoma-2 on the HIV reservoir
DOI: 10.1371/journal.ppat.10139232026
Journal article
Use of HIV Phylogenetic Analysis in Public Health in Victoria, Australia: Regulatory Considerations
DOI: 10.1007/s11673-025-10496-72026
Journal article
Immunotherapy and impact on tissue reservoirs
DOI: 10.1097/COH.00000000000009962026
Journal article
Analytical treatment interruption as a tool in the evaluation of immune-mediated interventions for long-term antiretroviral-free control of HIV-1 among people with HIV
DOI: 10.1016/j.cct.2025.1081442025
Journal article
Limitations and use of the Morpheus-V5 dual reporter virus in assessing interventions that target HIV latency
DOI: 10.1016/j.jviromet.2025.115236
RECENT PROJECTS
2023
Research contracts (non-grants)
REVEAL (Alfred MACH)
2025
Research grants (international)
Direct and Indirect Targeting of HIV Tat for Selective RNA Degradation and Protein Suppression